Have a personal or library account? Click to login
Efficacy and safety of monoclonal antibody therapy for chronic rhinosinusitis with nasal polyposis Cover

Efficacy and safety of monoclonal antibody therapy for chronic rhinosinusitis with nasal polyposis

Romanian Journal of Rhinology
Volume 12 (2022): Issue 48 (December 2022)
By: Raluca Enache,  Andreea Bejenariu and  Codrut Sarafoleanu  
Open Access
|Oct 2022

Authors

Raluca Enache

enache.raluca@yahoo.com

ENT Sarafoleanu Medical Clinic, Bucharest, Romania

Andreea Bejenariu

ENT Sarafoleanu Medical Clinic, Bucharest, Romania
ENT&HNS Department, “Sfanta Maria” Hospital, Bucharest, Romania

Codrut Sarafoleanu

ENT Sarafoleanu Medical Clinic, Bucharest, Romania
ENT&HNS Department, “Sfanta Maria” Hospital, Bucharest, Romania
CESITO Center, “Sfanta Maria” Hospital, Bucharest, Romania
DOI: https://doi.org/10.2478/rjr-2022-0024 | Journal eISSN: 2393-3356 | Journal ISSN: 2069-6523
Journal RSS Feed
Language: English
Page range: 154 - 168
Submitted on: May 27, 2022
Accepted on: Jul 1, 2022
Published on: Oct 21, 2022
Published by: Romanian Rhinologic Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
nasal polyps,
chronic rhinosinusitis,
monoclonal antibodies,
inflammation
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Surgery,
Surgery, other,
Otorhinolaryngology,
Speech, voice and paediatric hearing disorders,
Oromaxillofacial surgery

© 2022 Raluca Enache, Andreea Bejenariu, Codrut Sarafoleanu, published by Romanian Rhinologic Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 12 (2022): Issue 48 (December 2022)Next article